BREAST CANCER RESEARCH AND TREATMENT
Scope & Guideline
Fostering Collaboration for Better Outcomes
Introduction
Aims and Scopes
- Clinical Trials and Patient Outcomes:
Research focused on clinical trials that assess the efficacy and safety of new treatments, including chemotherapy, targeted therapies, and immunotherapies, as well as studies that evaluate patient outcomes and quality of life. - Molecular and Genetic Insights:
Investigations into the molecular and genetic underpinnings of breast cancer, including studies on biomarkers, genetic mutations, and their implications for precision medicine and targeted therapies. - Epidemiology and Risk Factors:
Studies examining the epidemiology of breast cancer, including risk factors such as genetics, lifestyle, and environmental influences, as well as trends in incidence and mortality across different populations. - Innovative Diagnostic Techniques:
Research into new diagnostic methods, including imaging technologies and biomarker assays, that improve early detection and monitoring of breast cancer. - Psychosocial Factors and Survivorship:
Exploration of the psychosocial aspects of breast cancer, including the impact of diagnosis and treatment on mental health, coping mechanisms, and survivorship care. - Health Disparities and Access to Care:
Research addressing disparities in breast cancer outcomes related to socioeconomic status, race, and geographical location, as well as barriers to care and treatment adherence.
Trending and Emerging
- Precision Medicine and Genomics:
An increasing number of studies are focusing on precision medicine approaches, utilizing genomic and molecular profiling to tailor treatments to individual patients, thereby improving outcomes. - Immunotherapy and Targeted Therapies:
Research on immunotherapy and targeted therapies is on the rise, with studies exploring novel agents and combination therapies that enhance the immune response against breast cancer. - Quality of Life and Patient-Centered Care:
There is a growing emphasis on patient-reported outcomes, quality of life assessments, and psychosocial support for breast cancer survivors, highlighting the importance of holistic care. - Digital Health and Telemedicine:
The integration of digital health technologies and telemedicine in breast cancer care has gained traction, particularly in the wake of the COVID-19 pandemic, with studies exploring their effectiveness and patient acceptance. - Health Disparities and Equity in Care:
Emerging research is increasingly addressing health disparities in breast cancer outcomes, focusing on access to care, treatment adherence, and the influence of socioeconomic factors on patient experiences. - Microbiome and Its Role in Cancer:
Research exploring the role of the microbiome in breast cancer development and treatment responses is gaining momentum, indicating a new frontier in understanding cancer biology.
Declining or Waning
- Traditional Chemotherapy Approaches:
There is a noticeable decline in studies focusing solely on traditional chemotherapy regimens, as research increasingly shifts towards personalized medicine and targeted therapies that consider genetic and molecular profiles. - Basic Laboratory Research:
Research that primarily emphasizes basic laboratory findings without direct clinical application or relevance is becoming less prominent as the journal prioritizes translational research that bridges basic science and clinical outcomes. - Epidemiological Studies without Intervention:
Epidemiological studies that do not propose interventions or actionable insights are less frequently published, reflecting a trend towards research that not only identifies risk factors but also suggests ways to mitigate those risks. - Single-Cancer Focus Research:
There is a waning interest in research that examines breast cancer in isolation, with a growing emphasis on studies that consider breast cancer in the context of other comorbid conditions, such as obesity, diabetes, and mental health issues.
Similar Journals
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Championing Excellence in Cancer Research and Clinical Practice.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, published by Springer, is a prestigious peer-reviewed journal dedicated to advancing the fields of cancer research and clinical oncology. With an impact factor reflecting its significance within the academic community, the journal operates under a rigorous quality standard and offers a wealth of knowledge spanning from 1979 and continuing through 2025. With its comprehensive scope, it encompasses a wide array of topics including novel therapeutic strategies, clinical trials, and cutting-edge research methodologies, making it an essential resource for researchers, practitioners, and students alike. The journal’s category quartiles highlight its competitive edge, ranking Q2 in Cancer Research and Q1 in Medicine (miscellaneous) as of 2023. This positioning underscores its role at the forefront of oncology discourse. Through this journal, contributors and readers alike engage with impactful research that informs clinical practices and enhances patient care in oncology. Access to the journal’s content, although not open access, ensures curated and high-quality insights available to the academic and professional community.
INTERNATIONAL JOURNAL OF CANCER
Leading the charge in innovative cancer solutions.INTERNATIONAL JOURNAL OF CANCER, published by Wiley, stands as a premier platform for the dissemination of cutting-edge research in the fields of cancer research and oncology. With an impressive impact factor reflecting its rigorous peer-review process and significant contribution to the scientific community, this journal is categorized in Q1 for both Cancer Research and Oncology as of 2023. It boasts notable rankings, being placed 38th among 404 journals in Medicine - Oncology and 32nd among 230 in Biochemistry, Genetics, and Molecular Biology - Cancer Research, positioning it within the 90th and 86th percentiles, respectively. Since its inception in 1966 and continuing to 2024, the journal has played a pivotal role in advancing our understanding of cancer biology, treatment modalities, and innovative therapeutic approaches. While it operates under a subscription model, the journal is committed to making valuable research accessible to a broader scientific audience. Researchers, professionals, and students alike will find the INTERNATIONAL JOURNAL OF CANCER an essential resource for staying abreast of the latest advancements in cancer science.
Oncology Research and Treatment
Uniting researchers to combat cancer effectively.Oncology Research and Treatment, published by KARGER, is a highly regarded academic journal dedicated to advancing the field of oncology through rigorous research and clinical insights. With a history spanning from 1978 to 1997 and continuing from 2013 to 2024, this journal provides a vital platform for researchers and professionals in cancer research, hematology, and related disciplines. Though currently listed in the Q3 tier of 2023 for Cancer Research, Hematology, and Oncology, its growing readership and open access policy enhance its visibility and impact within the scientific community. Based in Switzerland, the journal features diverse access options, reflecting the global importance of oncology research. With a focus on innovative treatments and the latest methodologies, Oncology Research and Treatment plays a crucial role in fostering collaboration and dialogue among researchers, professionals, and students alike, helping to shape the future of cancer care and management.
ONCOLOGY
Connecting researchers and clinicians in the fight against cancer.ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.
Oncology Letters
Connecting Researchers to Revolutionize Cancer CareOncology Letters is a prominent academic journal dedicated to disseminating high-quality research in the fields of oncology and cancer research. Published by SPANDIDOS PUBL LTD and based in Greece, this journal has established a significant presence since its inception in 2010 and continues to contribute to the scientific community with a focus on both clinical and experimental oncology. Notably, it holds a respectable Q3 ranking in the categories of Cancer Research and Oncology as of 2023, highlighting its relevance and contribution to these critical fields. With a Scopus rank of #139/404 in Medicine – Oncology and #117/230 in Biochemistry, Genetics, and Molecular Biology – Cancer Research, Oncology Letters serves as a valuable platform for researchers, professionals, and students alike to explore emerging findings and innovative treatment approaches. Though it operates within a traditional subscription model, this journal prides itself on fostering accessible and impactful discourse in oncology, making it an essential resource for those committed to advancing cancer research and improving patient care.
Colorectal Cancer
Connecting Researchers for a Cancer-Free FutureColorectal Cancer is an esteemed academic journal published by Taylor & Francis Ltd, focusing on all aspects of colorectal cancer research, diagnosis, treatment, and prevention. With an ISSN of 1758-194X and an E-ISSN of 1758-1958, this journal serves as a critical platform for publishing innovative studies, clinical trials, and meta-analyses to advance the understanding of colorectal cancer. Though not yet categorized under open access, it provides valuable insights and is committed to enhancing the visibility of research contributions within the field. The journal aims to foster collaboration and communication among researchers, clinicians, and students dedicated to improving patient outcomes and exploring novel therapeutic strategies. With its rigorous editorial standards, Colorectal Cancer plays a pivotal role in shaping future research and clinical practices, making it indispensable for professionals in oncology, gastroenterology, and related fields.
eCancerMedicalScience
Fostering insights for a world free of cancer.eCancerMedicalScience, a leading open-access journal published by the eCancer Global Foundation, is dedicated to advancing the field of cancer research and oncology. With its inception in 2007, this esteemed journal has emerged as a pivotal platform for disseminating groundbreaking research, innovative treatments, and comprehensive reviews in the cancer domain. Based in the United Kingdom, eCancerMedicalScience has continuously contributed to the academic community with its rigorous peer-review process and broad-ranging scope, now encompassing topics from clinical oncology to molecular biology. Currently ranked in the Q3 quartile for both Cancer Research and Oncology in 2023, the journal provides a significant opportunity for researchers, professionals, and students to access valuable insights and share their findings within a global network. The commitment to open access ensures that knowledge is readily available, fostering collaborative efforts to combat cancer and improve patient outcomes.
Current Breast Cancer Reports
Connecting Science and Solutions for Breast Cancer.Current Breast Cancer Reports is a vital academic journal published by Springer that focuses on the latest research and advancements in the field of breast cancer. With its ISSN 1943-4588 and E-ISSN 1943-4596, this journal serves as an essential resource for oncologists, researchers, and healthcare professionals dedicated to improving diagnosis and treatment strategies for breast cancer. Spanning from 2009 to 2024, it provides a platform for high-quality, peer-reviewed articles that encompass a range of topics, including molecular biology, clinical trials, and innovative therapeutic approaches. Although it is currently classified in the Q3 category in Oncology and is positioned in the 29th percentile, the journal remains committed to elevating its academic impact and contributing meaningfully to the ongoing fight against breast cancer. As it seeks to disseminate critical findings and foster collaboration within the scientific community, Current Breast Cancer Reports is poised to be an indispensable tool for anyone keen on advancing the field.
Journal of Cancer
Connecting researchers to transform cancer care.Journal of Cancer is a premier, peer-reviewed academic journal published by IVYSPRING INTERNATIONAL PUBLISHING that focuses on advancing the field of oncology. With an impact factor reflecting its significant contributions, this journal ranks in the 80th percentile of medical journals pertaining to oncology, positioning it at #79 out of 404 in Scopus. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that groundbreaking research reaches a global audience without barriers. Based in Australia, the journal addresses a wide array of topics within cancer research, catering to researchers, healthcare professionals, and students committed to enhancing their understanding of the complexities of cancer. Amidst evolving challenges in oncology, the Journal of Cancer serves as a vital platform for disseminating innovative findings, fostering collaboration, and promoting informed decisions that can lead to improved cancer outcomes worldwide.
Breast Cancer
Empowering breakthroughs in oncology and pharmacology.Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.